Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
SGMO.OQ - Sangamo Therapeutics Inc
Sangamo Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual)
Dec 01, 2022 / 03:30PM GMT
=====================
Conference Call Participants
=====================
* Liisa Bayko
Evercore ISI - Analyst
=====================
Presentation
--------------------------------------------------------------------------------
Liisa Bayko, Evercore ISI - Analyst [1]
--------------------------------------------------------------------------------
Hi there. This is Liisa Bayko, one of the analysts at Evercore ISI, and you're at HealthCONx on day three. And today, we're going to be talking to Sangamo for our fireside chat. They're one of the actually earlier gene editing companies. And I kind of have known them to different durations, but I think it's an interesting time. We're going to be doing this an audio only, there's some storm issues out in the bay area. But it should be a good conversation, nonetheless. What I'd like to do is just start with an overview of Sangamo for those
Trustpilot
